The Pharmacogenetics Research Network is a nationwide research effort sponsored by NIGMS and other NIH components that resulted from a 1998 recommendation by an NIGMS Pharmacogenetics Working Group. The network is a collaborative series of groups of scientists studying the effects of genes on people's responses to a wide variety of medicines. They are helping to create a pharmacogenetics knowledge base, the PharmGKB. The PGRN welcomes affiliate members with research interests and willingness to participate in network efforts.
Network Scientists and Research Project Summaries, 2005-
| Russ B. Altman, M.D., Ph.D. |
Pharmacogenetics and Pharmacogenomics Knowledge Base |
| Neal L. Benowitz, M.D. |
Pharmacogenetics of Nicotine Addiction and Treatment |
| David A. Flockhart, M.D., Ph.D. |
Consortium on Breast Cancer Pharmacogenomics |
| Kathleen M. Giacomini, Ph.D. |
Pharmacogenetics of Membrane Transporters |
| Julie A. Johnson, Pharm.D. |
Pharmacogenomic Evaluation of Antihypertensive Responses |
| Ronald M. Krauss, M.D. |
Pharmacogenetics Network for Cardiovascular Risk Therapy |
| Howard L. McLeod, Pharm.D. |
Functional Polymorphism Analysis in Drug Pathways |
| Mark Ratain, M.D. |
Pharmacogenetics of Anticancer Agents |
| Dan M. Roden, M.D. |
Pharmacogenomics of Arrhythmia Therapy |
| Alan R. Shuldiner, M.D. |
The Amish Pharmacogenomics of Anti-Platelet Intervention Study |
| Richard Weinshilboum, M.D. |
Pharmacogenetics of Phase II Drug Metabolizing Enzymes |
| Scott Weiss, M.D. |
Pharmacogenetics of Asthma Treatment |
Alumni, 2000-2005
Network Publications (slow connection)
This PubMed-linked listing is a compilation of publications citing the network awards.
External Scientific Panel for the PGRN, 2006-present
Governing Structure, 2007-present
Archives
